life science company
Navinci Diagnostics has raised €8.5M across 1 funding round from 4 investors, most recently a Series A round in Jul 2022. Based in Uppsala, Sweden; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-07-12 | Series A | €8.5M |
| Beijer Ventures,Landegren Gene Technology,Nexttobe,Segulah Medical Acceleration |
| View deal → |
